NeuroVive Pharmaceutical ABのEBITDA
NeuroVive Pharmaceutical ABのEBITDAは何ですか。
NeuroVive Pharmaceutical ABのEBITDAは-106.05krです。
EBITDAの定義は何ですか。
EBITDA は、会社の営業成績を表す利息、税金、減価償却費および償却費を控除する前の利益です。
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
LSEのセクタMiscellaneousにおけるEBITDAの企業と比べるNeuroVive Pharmaceutical AB
NeuroVive Pharmaceutical ABは何をしますか。
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
NeuroVive Pharmaceutical ABと類似のebitda
- Zodiac ClothingのEBITDAは-107.23₨です。
- Zillow IncのEBITDAは-107.00$です。
- Elastic N.VのEBITDAは-106.99$です。
- Larry Jewelry InternationalのEBITDAは-106.82HKD$です。
- Rush Street InteractiveのEBITDAは-106.72$です。
- Regional ExpressのEBITDAは-106.30AUD$です。
- NeuroVive Pharmaceutical ABのEBITDAは-106.05krです。
- Cranes Software InternationalのEBITDAは-106.04₨です。
- Centrica PlcのEBITDAは-106.00£です。
- Centrica PlcのEBITDAは-106.00£です。
- Hands Form LtdのEBITDAは-105.67HKD$です。
- Hands FormのEBITDAは-105.67HKD$です。
- Seritage Growth PropertiesのEBITDAは-105.57$です。